Evidence Question
What does direct evidence report when dulaglutide dose escalation is compared with tirzepatide for incidence of gastrointestinal disorders?
Related to: Adverse Events and SafetyShort answer
In indexed direct evidence at the reported timepoint, no difference was reported for incidence of gastrointestinal disorders.